The Coronavirus Disease (COVID-19) has created an economic and healthcare crisis.
In 2021, the North American region was expected to have the highest share of the global market over the forecast year. The strong presence of numerous players and the simple accessibility of cutting-edge healthcare infrastructure are credited with this. Additionally, the growth results from increased technologically advanced product innovations, significant per-person health expenditures, and the number of chronic patients.
In 2021, the United States region was anticipated to hold a significant global Huber needles market share. The U.S. FDA has authorized the use of Huber needles for long-term medication infusion and blood withdrawal. Huber needles are safety vascular access needles that fall under class II with unique controls.
The Huber needles market competitive landscape provides details of a competitor. Details include company financials, investment in research and development, revenue generated, market potential, global presence, new market initiatives, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance.
A Huber needle is a hollow, long needle with a tip that may penetrate skin and silicone septa during chemotherapy. Using Huber needles, lap-band adjustments, dialysis, blood transfusions, and intravenous cancer therapies. Huber needles come in various lengths and are used for various purposes. Globally, more people can get high-quality chemotherapy treatment, which affects market expansion. The market's growth factors include increased smoking behaviors, bad lifestyle choices, and physical inactivity. The market for Huber needles will grow overall due to an increase in cancer patients choosing chemotherapy. The rising demand for chemotherapy-related medical equipment and supplies will drive the market.
The key players in the global Huber needles market are focusing on adopting merger and acquisition strategies to expand their product portfolio. For instance, in February 2019, B. Braun Medical Inc. acquired Medisystems Streamline Bloodlines business that includes the Streamline Bloodline for the Dialog+ hemodialysis system, Streamline Bloodline for the Fresenius Medical Care hemodialysis system, and Streamline Bloodline Long for the Fresenius Medical Care hemodialysis system.
Some major players in the Huber needles market are B. Braun Medical Inc., Exel International, Smiths Medical, NIPRO Medical Corporations, Baxter International Inc., Medsurg and Novo Nordisk, C.R. Bard, Thiebaud S.A.S., AngioDynamics, Vygon S.A.
The increasing prevalence of cancer is one factor expected to drive the growth of the target market. A favorable reimbursement scenario for vascular access needles will also likely aid market growth. Due to the convenience and inherent advantages, Huber needles are witnessing growth globally. Additionally, Huber needles are widely used by more patients undergoing chemotherapy treatment. Increasing focus on reducing needle stick injuries has led many companies to develop and introduce various needles with safety features in the market.
The high risk of contamination and high cost of products are expected to curb the growth of the Huber needles market. In contrast, the lack of product innovations can challenge the development of the Huber needles market. The risk of infection associated with Huber needles is a major factor expected to restrain the Huber needles market growth during the forecast period.
The curved Huber needles deliver nutritional fluids, medications, and chemotherapy. Curve needles are more convenient than straight needles as they can be left in place for a few days. It also prevents the need to stick many needles.
North America is expected to dominate the Huber needle market due to the rising number of chronic patients. The increasing adoption of the Huber needle in transfusion, chemotherapy, and blood sampling to its easy accessibility is driving the market growth in this region. Growing usage in intravascular cancer treatments is also aiding the Huber needle industry growth in North America.
Asia Pacific regions are expected to have a significant growth rate in the market. The Asia Pacific, India, and China observed rapid growth in recent years. The increasing healthcare infrastructure and rising health awareness are expected to cause significant market growth in this region's Huber needle industry.
The Huber needle industry is projected to be aided by government regulations on needle stick injuries to ensure patient safety. According to the FDA, the basic structure of the Huber needle contains a needle, needle cap, and hub. These needles are either the straight type available in gauges 19, 20, and 22, and length 1" to 1-1/2" or bent 90-degree angle available in gauges 19, 20, and 22, and length 1" to 1-1/2"
The global market is projected to have a moderate growth rate of 4.50% in the upcoming years. The global Huber needles industry was estimated to be worth USD 45.2 million in 2021 and was projected to be worth USD 58.8 million by 2028.
Major players are increasingly focusing on Products with advanced features, such as self-retracting needles and needles with safety locking are gaining traction among healthcare professionals and patients. Manufacturers are also focusing on using standardized coring tests. This can help companies to develop a well-tested product, avoiding adverse health effects.
REPORT ATTRIBUTE | DETAILS |
---|---|
Market by Value |
Yes |
Market, Tornado Analysis |
Yes |
Market, STAR Analysis |
Yes |
Market, SRC Analysis |
Yes |
Market Pricing Analysis |
Yes (On Demand) |
Market Segment Analysis |
By Product (Straight Huber Needles and Curved Huber Needles) By Application (Transfusion of Blood, Application for Cancer, Parental Nutrition, and Others) By End user (Hospitals, Clinics, Ambulatory surgical centers, and Others) |
Market, Regional Analysis |
North America (the U.S. and Canada) Europe (Germany, UK, France, Italy, Spain, and the Rest of Europe) Asia Pacific (China, India, Japan, South Korea, Southeast Asia, and the Rest of Asia Pacific) Latin America (Brazil, Mexico, and the Rest of Latin America) The Middle East and Africa (GCC Countries, South Africa, and the Rest of the Middle East and Africa) |
Market Key Companies |
B. Braun Medical Inc., Exel International, Smiths Medical, NIPRO Medical Corporations, Baxter International Inc., Medsurg and Novo Nordsik, C.R. Bard, Thiebaud S.A.S., AngioDynamics, Vygon S.A. |
Market Competitive Landscape |
Market Share Analysis Competitive Benchmarking Key Players Market Positioning Geographical Presence Analysis Major Strategies Adopted |
Global Huber Needles Market – By Product
Global Huber Needles Market – By Application
Global Huber Needles Market – By End user
Global Huber Needles Market – By Region
The Coronavirus Disease (COVID-19) has created an economic and healthcare crisis.
Increased accessibility of quality therapy, as patients seek chemotherapy over surgical treatments, leads to increased scope for the Huber needle market.
The curved Huber needles segment had a major global market share in 2021.
The application for the cancer segment had a significant share in the global market.
Hospitals had a significant share in the global market.
Report Attribute | Details |
---|---|
Market Value in 2021 | USD 45.2 million |
Market Value in 2028 | USD 58.8 million |
CAGR | 4.50% |
Benchmarking Year | 2021 |
Past data | 2016 – 2021 |
Forecast period | 2022 – 2028 |